Pictures of Melanoma and Other Skin Cancers

Pictures of Melanoma and Other Skin CancersSkin cancer pictures can help you spot abnormalities that warrant evaluationByAngelica BottaroUpdated on October 28, 2023Medically reviewed

Updated on: January 28,2024

Pictures of Melanoma and Other Skin Cancers

Pictures of Melanoma and Other Skin CancersSkin cancer pictures can help you spot abnormalities that warrant evaluationByAngelica BottaroUpdated on October 28, 2023Medically reviewed

Updated on:January 28,2024

Scientists uncover novel DNA repair mechanism for key cancer target

byThe Francis Crick InstituteGraphical Abstract. Credit:Molecular Cell(2022). DOI: 10.1016/j.molcel.2022.11.008Scientists at the Francis Crick Institute, in collaboration with Artios

Updated on: December 27,2023

Scientists uncover novel DNA repair mechanism for key cancer target

byThe Francis Crick InstituteGraphical Abstract. Credit:Molecular Cell(2022). DOI: 10.1016/j.molcel.2022.11.008Scientists at the Francis Crick Institute, in collaboration with Artios

Updated on:December 27,2023

New AI model detects 90% of lymphatic cancer cases

by Chalmers University of TechnologyCredit:The Lancet Digital Health(2023). DOI: 10.1016/S2589-7500(23)00203-0Medical image analysis using AI has developed rapidly in recent years. No

Updated on: March 20,2024

New AI model detects 90% of lymphatic cancer cases

by Chalmers University of TechnologyCredit:The Lancet Digital Health(2023). DOI: 10.1016/S2589-7500(23)00203-0Medical image analysis using AI has developed rapidly in recent years. No

Updated on:March 20,2024

Immune cells trained to hunt tumors after scientists plant synthetic 'flags' on cancer

Updated on: June 15,2025

Immune cells trained to hunt tumors after scientists plant synthetic 'flags' on cancer

Updated on:June 15,2025

Adding capivasertib to fulvestrant improves progression-free survival of hormone receptor-positive breast cancer

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainIn patients with hormone receptor (HR)-positive, HER2-negative tumors resistant to aromatase inhibitors, addition of th

Updated on: December 26,2023

Adding capivasertib to fulvestrant improves progression-free survival of hormone receptor-positive breast cancer

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainIn patients with hormone receptor (HR)-positive, HER2-negative tumors resistant to aromatase inhibitors, addition of th

Updated on:December 26,2023

Falling PSA levels found to predict longer survival in prostate cancer patients at high risk of metastases

byWolters Kluwer HealthTwelve-month landmark analysis of overall survival (OS) by prostate-specific antigen (PSA) decline subgroup for enzalutamide-treated men. Data cutoff: October 15, 2019. Cr

Updated on: January 02,2024

Falling PSA levels found to predict longer survival in prostate cancer patients at high risk of metastases

byWolters Kluwer HealthTwelve-month landmark analysis of overall survival (OS) by prostate-specific antigen (PSA) decline subgroup for enzalutamide-treated men. Data cutoff: October 15, 2019. Cr

Updated on:January 02,2024

New recommendations aim to ease patient access to lung cancer clinical trials

byUT Southwestern Medical CenterLung CA seen on CXR. Credit:CC BY-SA 4.0James Heilman, MD/WikipediaA clinical trial is only as powerful as its participants. For years, researchers ha

Updated on: December 18,2023

New recommendations aim to ease patient access to lung cancer clinical trials

byUT Southwestern Medical CenterLung CA seen on CXR. Credit:CC BY-SA 4.0James Heilman, MD/WikipediaA clinical trial is only as powerful as its participants. For years, researchers ha

Updated on:December 18,2023

NCI-MATCH: T-DM1 shows promising activity in salivary gland cancer

by ECOG-ACRIN Cancer Research GroupDr. Komal Jhaveri of Memorial Sloan Kettering Cancer Center in New York is the lead researcher for the NCI-MATCH precision medicine clinical trial's treatment ar

Updated on: December 20,2023

NCI-MATCH: T-DM1 shows promising activity in salivary gland cancer

by ECOG-ACRIN Cancer Research GroupDr. Komal Jhaveri of Memorial Sloan Kettering Cancer Center in New York is the lead researcher for the NCI-MATCH precision medicine clinical trial's treatment ar

Updated on:December 20,2023

'Universal' blood test for earlier diagnosis of cancer moves closer to market

byUniversity of BradfordUK researchers behind a potential 'universal' liquid biopsy blood test for cancer detection have licensed the technology to an industrial partner to take it to ma

Updated on: December 18,2023

'Universal' blood test for earlier diagnosis of cancer moves closer to market

byUniversity of BradfordUK researchers behind a potential 'universal' liquid biopsy blood test for cancer detection have licensed the technology to an industrial partner to take it to ma

Updated on:December 18,2023

Genetic study provides most comprehensive map of risk to date of breast cancer risk

byUniversity of CambridgeCredit: CC0 Public DomainA major international study of the genetics of breast cancer has identified more than 350 DNA 'errors' that increase an individual's

Updated on: December 20,2023

Genetic study provides most comprehensive map of risk to date of breast cancer risk

byUniversity of CambridgeCredit: CC0 Public DomainA major international study of the genetics of breast cancer has identified more than 350 DNA 'errors' that increase an individual's

Updated on:December 20,2023

Scientists find new marker that predicts early recurrence of breast cancer

byMedical College of WisconsinPD-L2 immunostaining in ER+ breast cancer. (A-C; brown signal) Immunohistochemistry of PD-L2 using diaminobenzidine chromogen and (D-F; red signal) immunofluorescen

Updated on: December 27,2023

Scientists find new marker that predicts early recurrence of breast cancer

byMedical College of WisconsinPD-L2 immunostaining in ER+ breast cancer. (A-C; brown signal) Immunohistochemistry of PD-L2 using diaminobenzidine chromogen and (D-F; red signal) immunofluorescen

Updated on:December 27,2023

Research identifies new route for tackling drug resistance in skin cancer cells

byQueen Mary, University of LondonA drug-resistant melanoma cell that has altered its cytoskeleton. Credit: Queen Mary University of LondonResearchers have found that melanoma cells fight anti-c

Updated on: December 20,2023

Research identifies new route for tackling drug resistance in skin cancer cells

byQueen Mary, University of LondonA drug-resistant melanoma cell that has altered its cytoskeleton. Credit: Queen Mary University of LondonResearchers have found that melanoma cells fight anti-c

Updated on:December 20,2023